Helix BioPharma Corp. (HBP, HBP.TO) Thursday reported a third-quarter loss of $2.87 million or $0.04 per share, compared to $2.88 million or $0.05 per share in the same period last year. The loss narrowed helped mainly by lower operating expenses.
Third-quarter revenues totaled $1.00 million, down 7.8 percent from $1.09 million last year.
Operating expenses for the quarter decreased to $3.89 million from $4.02 million last year.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.